Search

Search Constraints

You searched for: Author/Creator Wolf, Douglas C.

Search Results

1. A 21st century roadmap for human health risk assessment. (August 2014)

2. A 21st century roadmap for human health risk assessment. (August 2014)

3. A predictive data-driven framework for endocrine prioritization: a triazole fungicide case study. (20th October 2016)

4. A Randomized, Double‐Blind, Placebo‐Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Results of the Maintenance Period of the TOUCHSTONE Study: 1841. (October 2015)

6. Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial. Issue 2 (14th November 2022)

7. Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's Disease. Issue 7 (13th April 2017)

8. Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's Disease. Issue 7 (July 2017)

9. Endoscopic and Clinical Efficacy Demonstrated With Oral Ozanimod in Moderately to Severely Active Crohn's Disease: 669. (October 2017)

10. Illustrative case using the RISK21 roadmap and matrix: prioritization for evaluation of chemicals found in drinking water. (2nd January 2016)